EPO and glioblastoma: We revealed the markedly decreased cell death of IDO1 overexpression on GBM cells by the ferroptosis inducers (Erastin, ML-210), moderately by the apoptosis inducers (EPO and DDP), and hardly by the necrosis inducers (Emodin and TMZ).